Figures computed from official regulatory filings — .
Analysttarget 28.58 USD (+26%) · consensus 3.92/5 · 8 buy · 5 hold · 0 sell
Ownershipinsiders 1.28% · institutions 108.82% · short 11.3% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Option Care Health, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
68 buys302 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Bhatia Prateek | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Bhatia Prateek | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| BRANDT ERICtrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Pate R Cartertrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| BRANDT ERICtrack record | Award | $58.8K | Unusual size | SEC |
| Deckmann Natasha | Award | $18.8K | SEC |
| Bodem Barbara W. | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Wright Norman L. | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Bierbower Elizabeth D | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| SULLIVAN TIMOTHY P | Award | $107.5K | Unusual size | SEC |
| KRAEMER HARRY M JANSEN JRtrack record | Award | $268.5K | Unusual size | SEC |
| SULLIVAN TIMOTHY P | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| KRAEMER HARRY M JANSEN JRtrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Deckmann Natasha | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Smyser Collin | Other | $7.5K | SEC |
| Smyser Collin | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Smyser Collin | Exercise | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| SULLIVAN TIMOTHY P | Buy | $499.7K | conv 68Cluster | SEC |
| KRAEMER HARRY M JANSEN JRtrack record | Buy | $783.8K | conv 43Cluster | SEC |
| RADEMACHER JOHN CHARLES | Buy | $264.7K | conv 68ClusterFirst in 12mo | SEC |
| Sethna Meenal | Buy | $327.1K | conv 76ClusterFirst in 12mo | SEC |
| Adewunmi Femi | Other | $39.6K | SEC |
| Pate R Cartertrack record | Sell | $970.7K | Unusual size | SEC |
| Bavaro Michael | Sell | $198K | SEC |
| Whitworth Luke | Other | $155.7K | SEC |